DNB PHARMA LIMITEDActive

Company number 08032093Private limited companyIncorporated 2012

Key figures

£1,349,056+23.3%
Net assets 2024/25
+34.4%
Average annual growth 2019/20–2024/25
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, DNB PHARMA LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand396,240—592,856458,639507,844
Total assets552,1801,545,1522,041,7661,161,2192,267,232
Total liabilities938,323866,2511,056,526863,053—
Net assets / total equity259,192635,372941,7111,094,2541,349,056
Average number of employees8910-1212

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DNB PHARMA LIMITED

Company

DNB PHARMA LIMITED is a private limited company registered with Companies House under company number 08032093. It was incorporated on 16 Apr 2012. Its status is active. The registered office is in Stoke-on-trent (ST3). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £1,349,056, up 23.3% on the previous year. Cash at bank and in hand was £507,844. The company had an average of 12 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered. 2 of 2 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 24 Apr 2027.